CDC Website CDC Website

To Join the NPIN community or

Home » Innate Immune Memory Impacting HIV Acquisition and/or Control (R21 Clinical Trial Not Allowed)

COVID-19: General Information | Testing | Vaccines |

Contact Organizations directly about changes to services or hours

Innate Immune Memory Impacting HIV Acquisition and/or Control (R21 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity Announcement is to investigate innate immune cell effector functions and innate immune memory as a means to prevent HIV infection and/or establishment of disease. Exploratory research from basic molecular mechanisms, translational work, and clinical research examining innate memory are encouraged.

Letter of Intent Date
11/6/21
Application Due Date
12/6/21
Project Start Date
7/1/22
Application Contact
Ann
Devine
Branch Chief, Grants Management Officer/AIDS and CTU Division Coordinator
240-669-2988
adevine@niaid.nih.gov
Technical Contact
Que
Dang, Ph.D.
Scientific/Research Contact
que.dang@nih.gov
240-292-6181
Fund Duration
The total project period may not exceed two years.
Subjects
Audiences

Fund Number: 

359552

Fund ID: 

RFA-AI-21-041

Last modified: 

7/7/21